- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04534244
Impact of Endovenous Water Vapor Treatment on Quality of Life in Superficial Venous Insufficiency of the Lower Limbs (INVOLVE)
Management of Tributary Veins in Superficial Venous Insufficiency of the Lower Limbs: Impact of Endovenous Steam Treatment Versus Phlebectomy on Quality of Life
The prevalence of superficial chronic venous insufficiency (CVI) of the lower limbs is estimated at 18 million French people. The number of patients operated for varicose veins is around 300,000 per year. Post-operative complications such as venous ulcer, venous thrombosis and varicose vein rupture require a lot of medical care. Varicose veins are responsible for a decrease in quality of life and represents 1 to 2% of total health expenditure.
Currently, operating techniques tend towards minimally invasive procedures in order to minimize the surgical trauma, improve patient comfort and reduce the time of postoperative work stoppages.
This study aims to compare two surgical techniques for the treatment of superficial chronic venous insufficiency of the lower limbs : phlebectomy, the gold-standard technique, and endovenous steam treatment. Several studies have already been carried out on endovenous steam treatment for saphenous veins but none has been published concerning the tributary veins.The main objective of INVOLVE is to assess the quality of life of patients 1 month after surgery. Clinical improvement and economic impact will also be evaluated.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potential, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)
- Signature of the informed consent to participate indicating that the subject has understood the purpose and procedures required by the study and that he agrees to participate in the study and to comply with the requirements and restrictions inherent in this study
- Affiliation to a French social security scheme or beneficiary of such a scheme
- Patient with a reflux of the tributary veins, associated or not with a reflux of the large saphenous veins
- Patient with a reflux of the tributary veins already treated for a reflux at the saphenous level
- Clinical stage between C2 and C5 (from the CEAP classification). Diameter of the vein between 3 and 13 mm
- Patient treated with one or two lower limbs
- Patient able to understand and complete a quality of life questionnaire
Exclusion Criteria:
- Legal incapacity or limited legal capacity
- Subject unlikely to cooperate with the study and / or weak cooperation anticipated by the investigator
- Subject without health insurance
- Pregnant woman
- Subject in the period of exclusion from another study or provided for by the "national file of volunteers"
- Patient with an absolute or relative contraindication to the treatment of his varicose veins by an endovenous technique
- Venous insufficiency at the expense of the small saphenous vein
- Patient with a history of venous thrombosis
- Patient with hemostasis disorders
- Patient with an associated severe pathology (cancer, heart failure, renal failure)
- Patient treated with sclerotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control group
Treatment of the tributary veins by phlebectomy
|
|
|
EXPERIMENTAL: Experimental group
Endovenous steam treatment of the tributary veins
|
Medical device intended to treat permanent venous insufficiency of saphenous veins and tributary veins in patients with superficial venous reflux
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the quality of life relative to the health of patients after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: one month after the intervention
|
Questionnaire : VEnous INsufficiency Epidemiological and Economic Study on Quality of Life/Symptoms (VEINES-QOL/Sym) : target dimension " VEINES-QoL symptom summary score ".
High values indicate better outcomes.
|
one month after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the evolution of the quality of life relating to health of patients after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: 8-15 days, 3, 6, 9 and 12 months after the intervention
|
Questionnaires : VEnous INsufficiency Epidemiological and Economic Study on Quality of Life/Symptoms (VEINES-QOL/Sym), 36-Item Short Form Survey Instrument (SF36). The scores range from zero where the respondent has the worst possible health to 100 where the respondent is in the best possible health. |
8-15 days, 3, 6, 9 and 12 months after the intervention
|
|
Comparison of occlusion of the tributary veins after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: 8-15 days and one year after the intervention
|
Occlusion rate evaluated by Doppler ultrasound
|
8-15 days and one year after the intervention
|
|
Evaluation of the period of resumption of activity for people in activity after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: up to 1 year
|
Duration of work stoppage for working people
|
up to 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of secondary complications after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: 8-15 days, 1, 6 and 12 months after the intervention
|
The frequency, nature and severity of adverse events or immediate complications: hematomas, infections and burns requiring or not requiring intervention
|
8-15 days, 1, 6 and 12 months after the intervention
|
|
Comparison of postoperative pain after endovenous steam treatment versus phlebectomy of the tributary veins
Time Frame: Daily for the first 8 days after surgery
|
Assessment of daily pain by the visual analogue pain assessment scale for 8 days.
The scores range from zero where the respondent has the most pain to 10 where the respondent has the least pain.
|
Daily for the first 8 days after surgery
|
|
Comparison of the clinical improvement felt by the patient
Time Frame: 1, 6 months and one year after the intervention
|
Clinical improvement felt by the patient assessed by the Venous Clinical Severity Score (VCSS). Scores that can be obtained range between 0 and 30. Low values indicate better outcomes. |
1, 6 months and one year after the intervention
|
|
Evaluation of the economic impact of endovenous steam treatment in the management of superficial venous insufficiency of the lower limbs (cost-utility and cost-effectiveness analyzes)
Time Frame: 8-15 days, 1, 3, 6, 9 and 12 months after the intervention
|
Estimation of the differential cost-result ratio, evaluation of utility via EQ-5D Low values indicate better outcomes
|
8-15 days, 1, 3, 6, 9 and 12 months after the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- API/2020/103
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Insufficiency of Leg
-
Société d'Exploitation des Thermes d'AmnévilleSlb PharmaRecruiting
-
Universidade do PortoCompletedDrainage | Venous Insufficiency of Leg | Chronic Venous DiseasePortugal
-
University of Nove de JulhoNot yet recruitingVenous Leg Ulcer | Venous Insufficiency of Leg | Venous Disease | Venous Leg Ulcer (VLU) | Venous Insufficiency (Chronic)(Peripheral) | Varicose Ulcers | Venous Hypertension Ulcers | Varicose Ulcer of Lower LimbBrazil
-
Medtronic EndovascularCompletedVenous Insufficiency of LegUnited Kingdom, Denmark, Germany, Netherlands
-
Medtronic EndovascularCompleted
-
DeRoyal Industries, Inc.Royal College of Surgeons, Ireland; Enterprise Ireland; Tyndall National InstituteCompletedVenous Leg Ulcer | Venous Insufficiency of LegIreland
-
MED Institute Inc.Active, not recruitingVenous Insufficiency of LegColombia
-
University of ZurichRecruitingVenous Insufficiency of LegSwitzerland
-
State Budgetary Healthcare Institution, National...CompletedEndothelial Dysfunction | Venous Insufficiency of Leg | Venous Insufficiency (Chronic)(Peripheral)Russian Federation
-
Chang Gung Memorial HospitalRecruitingVenous Leg Ulcer | Venous Insufficiency of Leg | Venous Occlusion | Contrast Media ReactionTaiwan
Clinical Trials on VBox Hybrid
-
Jessa HospitalTerminatedCoronary Artery DiseaseBelgium
-
Erasmus Medical CenterMedtronic; Alrijne HospitalNot yet recruitingIncisional Hernia of Midline of AbdomenNetherlands
-
Lawson Health Research InstituteLondon Health Sciences CentreCompleted
-
Chang Gung Memorial HospitalUnknown
-
Instituto Nacional de Cancerologia de MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto... and other collaboratorsRecruitingBreast NeoplasmMexico
-
Radboud University Medical CenterNot yet recruitingHeart Failure | Diabetes Type 2Netherlands, Italy, Malta, Slovenia
-
Örebro University, SwedenActive, not recruitingChronic Pain | Emotional ProblemSweden
-
Al-Azhar UniversityActive, not recruiting
-
University of Roma La SapienzaNot yet recruitingCoronary Artery Disease
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Sengkang...Not yet recruitingHyperaldosteronism; Primary | Primary Aldosteronism Due to Aldosterone Producing AdenomaSingapore